Participants 115 130 3
type 2 diabetes
Participants 460 590 3
patients who had diabetes and had already been treated with angiotensin II receptor blockers and with or without thiazolidinedione
Participants 652 807 6
Forty patients who had diabetes with nephropathy and arteriosclerosis obliterans and had already been treated with angiotensin II receptor blocker (n = 40)
